Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection

ClinicalTrials.gov ID: NCT00908388

Public ClinicalTrials.gov record NCT00908388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT00908388
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: W.L.Gore & Associates; Industry
Enrollment: 50 participants

Conditions and interventions

Conditions

Type B Aortic Dissection

Interventions

GORE TAG® Thoracic Endoprosthesis Device

Device

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2009
Primary completion: Jan 31, 2012
Completion: Feb 27, 2017
Last update posted: Oct 26, 2017

2009 – 2017

United States locations

U.S. sites: 37
U.S. states: 21
U.S. cities: 34

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35294	—
Not listed	Los Angeles	California	90095	—
Not listed	San Francisco	California	94143	—
Not listed	Stanford	California	4305	—
Not listed	Torrance	California	90509	—
Not listed	Gainesville	Florida	32610	—
Not listed	St. Petersburg	Florida	33709	—
Not listed	Tampa	Florida	33606	—
Not listed	Atlanta	Georgia	30322	—
Not listed	Chicago	Illinois	60611	—
Not listed	Peoria	Illinois	61614	—
Not listed	Indianapolis	Indiana	46202	—
Not listed	Kansas City	Kansas	66160	—
Not listed	Baltimore	Maryland	21287	—
Not listed	Boston	Massachusetts	02114	—
Not listed	Boston	Massachusetts	02215	—
Not listed	Ann Arbor	Michigan	48109	—
Not listed	Grand Rapids	Michigan	49546	—
Not listed	Minneapolis	Minnesota	55407	—
Not listed	Minneapolis	Minnesota	55455	—
Not listed	Plymouth	Minnesota	55441	—
Not listed	St Louis	Missouri	63110	—
Not listed	St Louis	Missouri	63141	—
Not listed	Lebanon	New Hampshire	03756	—
Not listed	Albany	New York	12208	—
Not listed	New York	New York	10032	—
Not listed	Chapel Hill	North Carolina	27599	—
Not listed	Charlotte	North Carolina	28204	—
Not listed	Durham	North Carolina	27710	—
Not listed	Cleveland	Ohio	44195	—
Not listed	Philadelphia	Pennsylvania	19104	—
Not listed	Pittsburgh	Pennsylvania	15213	—
Not listed	Memphis	Tennessee	38120	—
Not listed	Houston	Texas	77030	—
Not listed	Temple	Texas	76508	—
Not listed	Charlottesville	Virginia	22908	—
Not listed	Madison	Wisconsin	53792	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00908388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 26, 2017 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00908388 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →